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Background: Solobacterium moorei is a volatile sulfide compound (VSC)-producing Gram-positive anaerobic bacterium
that has been associated with halitosis. The aim of this study was to investigate the effects of green tea extract and its
major constituent epigallocatechin-3-gallate (EGCG) on growth and several halitosis-related properties of S. moorei.
Methods: A microplate dilution assay was used to determine the antibacterial activity of green tea extract and EGCG
against S. moorei. Their effects on bacterial cell membrane integrity were investigated by transmission electron
microscopy and a fluorescence-based permeability assay. Biofilm formation was quantified by crystal violet staining.
Adhesion of FITC-labeled S. moorei to oral epithelial cells was monitored by fluorometry. The modulation of
β-galactosidase gene expression in S. moorei was evaluated by quantitative RT-PCR.
Results: The green tea extract as well as EGCG inhibited the growth of S. moorei, with MIC values of 500 and 250 μg/ml,
respectively. Transmission electron microscopy analysis and a permeabilization assay brought evidence that the bacterial
cell membrane was the target of green tea polyphenols. Regarding the effects of green tea polyphenols on the S. moorei
colonization properties, it was found that biofilm formation on EGCG-treated surfaces was significantly affected, and that
green tea extract and EGCG can cause the eradication of pre-formed S. moorei biofilms. Moreover, both the green tea
extract and EGCG were found to reduce the adherence of S. moorei to oral epithelial cells. The β-galactosidase activity of
S. moorei, which plays a key role in VSC production, was dose-dependently inhibited by green tea polyphenols. In
addition, EGCG at ½ MIC significantly decreased the β-galactosidase gene expression.
Conclusion: Our study brought evidence to support that green tea polyphenols possess a number of properties that
may contribute to reduce S. moorei-related halitosis. Therefore, these natural compounds may be of interest to be used to
supplement oral healthcare products.
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Tea, an aqueous aromatic infusion of dried leaves of the
plant Camellia sinensis, is the most widely consumed bev-
erage in the world after water. More specifically, green tea
is made of non-fermented leaves and has a high catechin
content (flavan-3-ols), including epigallocatechin-3-gallate
(EGCG) that represents about 59% of total catechins [1].
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unless otherwise stated.green tea polyphenols may contribute to reducing the risk
and/or severity of many systemic conditions and diseases,
such as diabetes, cardiovascular disease and cancer [1-3].
The beneficial properties of green tea polyphenols have
been mostly associated to their anti-inflammatory, anti-
mutagenic, and anti-oxidative properties [1-3].
Epidemiological and clinical studies have provided
some evidence that green tea consumption may have po-
tential oral health benefits thus resulting in a decreased
incidence/severity of dental caries and periodontal dis-
eases, the two most common oral infections [4-8]. On
the one hand, the ability of green tea polyphenols toThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and acid production may contribute to its beneficial ef-
fects for dental caries [9-11]. On the other hand, the
positive impact of green tea polyphenols for periodontal
diseases may be associated to their ability to inhibit
growth, adherence, and protease activity of Porphyromo-
nas gingivalis [12,13], a major pathogen causing chronic
periodontitis. Moreover, it has been shown that green tea
polyphenols can exert anti-inflammatory properties by de-
creasing the secretion of interleukin-6, interleukin-8, and
C-C motif chemokine ligand 5 (CCL5) by P. gingivalis-
stimulated gingival epithelial cells [13]. Recently, our
laboratory reported that green tea extract and its major
constituent EGCG induce the secretion of β-defensins, a
family of antimicrobial peptides, by gingival epithelial cells
[14]. This property of green tea polyphenols to increase
epithelial β-defensin secretion may have a positive impact
by strengthening the epithelial antimicrobial barrier.
Halitosis (oral malodor) that affects a large proportion
of the population is a condition in which a person suf-
fers from bad breath. Bad breath originating from the
oral cavity is due to volatile sulfide compounds (VSCs)
generated through bacterial metabolism [15,16]. The
dorso-posterior region of the tongue is a major source of
oral malodor [17]. More particularly, proteolytic bacteria
found in tongue coating degrade proteins leading to the
production of cysteine and methionine which are further
processed into hydrogen sulfide and methylmercaptan
by specific bacterial species [15,16]. The basic treatment
for oral malodor includes mechanical removal of the
tongue coating with toothbrushes or tongue scrapers
[18]. In addition, the use of oral care products supple-
mented with chemicals effective in preventing bacterial
growth (chlorhexidine, cetylpyridinium chloride, triclo-
san, essential oils) or neutralizing VSCs (chlorine diox-
ide, zinc salts) can improve the condition significantly
[18]. Few studies have also brought evidence that green
tea polyphenols may be effective in reducing halitosis
[19,20]. The efficacy of green tea polyphenols for hali-
tosis has been related to their ability to modify VSCs
that results in a deodorant activity [19,21].
The Gram-positive anaerobic bacterium Solobacterium
moorei has been specifically associated with oral mal-
odor since it has been reported to be present in subjects
with halitosis but not in control subjects [22-24]. As a
matter of fact, Haraszthy et al. [22] detected S. moorei in
100% of the 21 subjects with halitosis compared to only
14% of the control subjects. Recently, Vancauwenberghe
et al. [25] reported a significant correlation between
S. moorei, tongue coating and total VSCs. In a previous
study, we showed that S. moorei can be a major source
of malodorous compounds by producing VSCs from
mucin through a process involving the cell-associated β-
galactosidase activity of the bacterium and an exogenoussource of proteases [26]. In this study, we investigated
the effects of a green tea extract and its major constitu-
ent EGCG on growth and several halitosis-related prop-
erties of S. moorei.
Methods
Green tea extract and epigallocatechin-3-gallate
The commercial green tea extract (Organic Herb Inc.,
Changsha, China) used in this study had a polyphenol
content ≥ 98%, including 45% EGCG, according to the
company’s data sheet. A stock solution was freshly pre-
pared by dissolving 20 mg of powder in one ml of sterile
warm distilled water and filtering the solution through a
0.2 μm-pore membrane filter. EGCG (Sigma-Aldrich
Canada Ltd, Oakville, ON, Canada), the major catechin in
green tea, was also dissolved in sterile distilled water at a
concentration of 5 mg/ml and was filter sterilized as above.
Bacteria and culture conditions
S. moorei CH8-20, kindly provided by V. Haraszthy (The
State University of New York at Buffalo), was used in
this study. This strain was isolated from the dorsal sur-
face of the tongue in a subject with halitosis [22]. Bac-
teria were routinely grown in Todd-Hewitt Broth (THB)
medium (BBL Microbiology Systems, Cockeysville, MD,
USA) supplemented with 0.001% hemin, 0.0001% vitamin K,
0.5% Tween-80, 0.2% yeast extract, and 1% glucose. Incu-
bation was carried out at 37°C under anaerobic conditions
(N2:H2:CO2/75:10:15).
Determination of minimal inhibitory concentrations and
minimal bactericidal concentrations
Minimal inhibitory concentrations (MICs) and minimal
bactericidal concentrations (MBCs) were determined
using a microbroth dilution assay as described in a previous
study [27]. Penicillin G was used as reference compound.
MIC values (μg/ml) of compounds were determined as the
lowest concentration at which no growth occurred. To de-
termine MBC values (μg/ml), aliquots (5 μl) of each well
showing no visible growth were spread on blood-
supplemented THB agar plates, which were incubated
for 3 days at 37°C. MBCs of compounds were deter-
mined as the lowest concentration at which no colony
formation occurred. The MIC and MBC values were de-
termined in three independent experiments.
Transmission electron microscopy analysis of
bacterial cells
S. moorei was grown as above, harvested by centrifuga-
tion, and washed once in 50 mM phosphate-buffered sa-
line pH 7.2 (PBS). Cells were suspended in PBS at an
OD660 of 0.5 and incubated in the presence of either
green tea extract (500 μg/ml) or EGCG (250 μg/ml) at
room temperature for 4 h. Thereafter, bacteria were fixed
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(pH 7) containing 5% glutaraldehyde and 0.15% ruthenium
red. Cells were then reacted with polycationic ferritin
(1 mg/ml) and processed as described by Vanrobaeys et al.
[28]. Thin sections were examined using a JEOL 1230
transmission electron microscope at an accelerating volt-
age of 80 kV.
Cell membrane permeability assay
The effect of green tea extract and EGCG on cell mem-
brane permeability of S. moorei was determined using
the intracellular dye calcein acetoxymethyl ester (cal-
cein-AM) (Sigma-Aldrich Canada Ltd), as previously de-
scribed [29]. Briefly, S. moorei cells were suspended in
PBS at an OD660 of 0.1 and one ml was incubated in the
presence of 5 μl of 1 mM calcein-AM for 4 h at room
temperature. Bacteria were then washed twice and sus-
pended in 2 ml of PBS. Calcein-AM-loaded bacteria
were dispensed (100 μl) into wells of a black 96-well mi-
croplate, and incubated at room temperature in the
presence of either green tea extract (500 μg/ml) or
EGCG (250 μg/ml). The release of calcein-AM resulting
from cell damages was monitored every 10 min during
160 min using a microplate reader at excitation wavelength
of 485 nm and emission wavelength of 530 nm. PBS was
used as negative control while heat-treated (80°C/10 min)
cells were used as positive control.
Biofilm formation and desorption
The effect of treating wells of a microplate with either
green tea extract or EGCG (1000 to 3.125 μg/ml) for 2 h
(room temperature) on biofilm formation by S. moorei
was assessed. Wells treated with PBS served as control.
Following treatment, a 24-h culture of S. moorei was di-
luted in fresh broth medium to obtain an OD660 of 0.1.
Samples (200 μl) were added to treated wells of a 96-
well microplate. After incubation for 48 h at 37°C under
anaerobic conditions, spent media and free-floating bac-
teria were removed by aspiration using a 26 g needle.
The wells were washed once with PBS and the S. moorei
biofilms were stained with 0.05% crystal violet (100 μl)
for 15 min. The wells were washed four times with PBS
to remove unbound crystal violet dye and dried for 2 h
at 37°C. After adding 100 μl of 95% (v/v) ethanol to each
well, the plate was shaken for 10 min to release the stain
from the biofilms and the absorbance at 550 nm (A550)
was recorded. In addition, the capacity of green tea ex-
tract and EGCG to promote biofilm desorption was in-
vestigated. Briefly, 48-h pre-formed S. moorei biofilms in
microplate were treated for 2 h under anaerobiosis with
either green tea extract or EGCG (1000 to 31.25 μg/ml).
Following these treatments, the biofilms were washed
twice with PBS and stained with crystal violet as above.
Biofilms treated with PBS were used as control.Adherence assay to oral epithelial cells
S. moorei cells cultivated as above were labeled with
fluorescein isothyocyanate (FITC) as previously reported
[30]. The immortalized human oral epithelial cell line
OBA-9 used in this study, kindly provided by Dr. Marcia
Mayer (Departamento de Microbiologia, Institute of Bio-
medical Sciences, Universidade de São Paulo, São Paulo,
Brazil), was initially described by Kusumoto et al. [31].
The epithelial cells were cultured (96-well microplate) in
Keratinocyte-Serum Free Medium (K-SFM, Life Tech-
nologies Inc., Burlington, ON, Canada) containing insu-
lin, epidermal growth factor, and fibroblast growth
factor, and supplemented with 100 μg/ml of penicillin
G/streptomycin at 37°C in a 5% CO2 atmosphere until
they reached confluence. The adherence assay of S.
moorei to epithelial cells in the absence or presence of
green tea extract or EGCG (200 to 3.125 μg/ml) was car-
ried out as described in a previous study [13]. After re-
moving unbound bacteria and washing wells, the relative
fluorescence units (RUF; excitation wavelength 495 nm;
emission wavelength 525 nm) corresponding to the de-
gree of bacterial adherence were determined using a
microplate reader.
Determination of β-galactosidase activity
The effect of green tea extract and EGCG on cell-
associated β-galactosidase activity of S. moorei was de-
termined using the chromogenic substrate o-nitrophe-
nyl-β-D-galactopyranoside (Sigma-Aldrich Canada Ltd).
Briefly, cells of S. moorei (OD660 = 2.0 in PBS) (100 μl)
were incubated with 25 μl of substrate (2 mg/ml) and
25 μl of green tea extract or EGCG (500 to 62.5 μg/ml).
The reaction mixtures were incubated at 37°C for 2 h
and bacteria were removed by centrifugation prior to
measure the absorbance at 405 nm (A405).
Determination of β-galactosidase gene expression by
quantitative RT-PCR
To investigate the effect of green tea extract and EGCG
on β-galactosidase gene expression, S. moorei was grown
to mid-log phase (OD660 = 0.4) and then compounds
were added at MIC (500 and 250 μg/ml for green tea ex-
tract and EGCG, respectively) and ½ MIC (250 and
125 μg/ml for green tea extract and EGCG, respectively)
prior to further incubate at 37°C for 8 h. Bacteria were
collected by centrifugation (7000 × g for 5 min) and
treated with an RNAprotect bacterial reagent (Qiagen
Canada Inc., Montreal, QC, Canada). Bacterial cells were
then lysed and RNA was isolated and purified using the
RNeasy minikit (Qiagen Canada Inc.). The amounts
of mRNA were quantified with the Experion™ system
(Bio-Rad Laboratories, Mississauga, ON, Canada). The
reverse transcription-polymerase chain reaction (RT-PCR)
to prepare cDNA was performed using the iScript™
Table 1 Minimal inhibitory concentration (MIC) and
minimal bactericidal concentration (MBC) values of
green extract, EGCG, and penicillin G for S. moorei
Compound MIC (μg/ml) MBC (μg/ml)
Green tea extract 500 4000
EGCG 250 > 4000
Penicillin G 0.098 6.25
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according to the manufacturer. Reverse transcription con-
ditions were 5 min at 25°C, 30 min at 42°C, and 5 min at
85°C. Real-time PCR was used for quantification of β-
galactosidase mRNA expression. 16S rRNA gene was used
as an internal control for data normalization. The primers
used for the quantitative RT-PCR were designed in this
study and purchased from Life Technologies Inc. The se-
quences of the forward and reverse primers used were
16SSmo-F: 5′-CTGTAGAGATACAGTAGAGGTTATC-3′
and 16SSmo-R: 5′-ATTGTAGTACGTGTGTAGCC-3′, re-
spectively, for 16S rRNA gene, and 1477Bgal778: 5′-GTA
TTCTTGATAGGTCTAAATCGTC-3′ and 1477Bgal946R:
5′-CAGTAAATACATACAAACCATAACG-3′, respect-
ively, for β-galactosidase gene. Triplicate reactions were
prepared with 10 μl of PCR mixture containing 5 μl of
IQ SYBR Green Supermix (Bio-Rad Laboratories), 4 μlFigure 1 Transmission electron microscopy analysis of S. moorei. Pane
green tea extract (500 μg/ml). Panels C and D: Bacteria treated (4 h) with Eof cDNA, 0.4 μl of gene-specific primer, and 0.6 μl of
RNase- and DNase-free water. The samples were ampli-
fied using a Bio-Rad MyCycler™ thermal cycler (Bio-Rad
Laboratories). The amplification conditions were 95°C
for 5 min followed by 35 cycles at 95°C for 1 min, 52°C
for 1 min and 72°C for 30 s. To validate the specificity
of each primer pair, temperature curve analyses
were performed.
Statistical analysis
All assays were performed in triplicate and the means ±
standard deviations were calculated. Differences between
means were analyzed for statistical significance using the
Student’s t-test and were considered significant at P < 0.01.Results
As reported in Table 1, both green tea extract and
EGCG exhibited antibacterial activity towards S. moorei.
On the one hand, the green tea extract had a MIC of
500 μg/ml while the MBC was 4000 μg/ml. On the other
hand, the MIC of EGCG was slightly lower at 250 μg/ml
although the MBC was found to be > 4000 μg/ml. As ex-
pected, penicillin G used as a reference control showed
much lower values of MIC (0.098 μg/ml) and MBC
(6.25 μg/ml).l A: Control untreated bacteria. Panel B: Bacteria treated (4 h) with
GCG (250 μg/ml).
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of S. moorei was evaluated by transmission electron micros-
copy (Figure 1). The ultrastructure of S. moorei cells treated
with green tea extract at the MIC (500 μg/ml) was not ob-
viously affected compared to control cells (Figure 1A,B).
However, in the electron micrographs of EGCG-treated
S. moorei cells, severe ultrastructural damages were ob-
served, which result in breakdown of the cytoplasmic
membrane and cell wall with leakage of the cytoplasmic
content (Figure 1C,D). In order to further investigate the
effects of green tea polyphenols on the cytoplasmic mem-
brane of S. moorei, the fluorescent dye calcein-AM was
used. The addition of green tea extract or EGCG, both at
MIC, to calcein-AM-loaded S. moorei cell suspensions
caused a time-dependent release of fluorescence (Figure 2).
The release of calcein-AM induced by green tea extract
was more significant compared to EGCG.
When growth of S. moorei was carried out in the pres-
ence of either green tea extract or EGCG, no specific
anti-biofilm effect was observed; the decreased biofilm
formation was related to growth inhibition caused by theFigure 2 Time course of green tea extract- and EGCG-induced release
(80°C/10 min) were used as negative and positive controls, respectively. Dagreen tea polyphenols (data not shown). However, as re-
ported in Figure 3, a pre-treatment of the polystyrene
surfaces of the microplate with EGCG was found to
dose-dependently reduce biofilm formation. Such treatment
did not affect bacterial growth. More specifically, pre-
treating the polystyrene wells with EGCG at 500 μg/ml
reduced S. moorei biofilm formation by 52%. Although
treatment of wells with the highest concentration of the
green tea extract decreased biofilm formation by S. moorei,
the inhibition was not significant.
The ability of green tea polyphenols to induce desorp-
tion of a pre-formed S. moorei biofilm was then investi-
gated. EGCG and to a lesser extent green tea extract
were found to dose-dependently desorb biofilms of
S. moorei following an exposition of 2 h (Figure 4). This
effect was found to be more pronounced for EGCG. At
125 μg/ml, EGCG completely eradicated S. moorei bio-
films, while at the same concentration the green tea ex-
tract had no significant effect.
Using fluorescein-labelled bacterial cells, S. moorei was
found to adhere to oral epithelial cells (Figure 5). Whenof calcein-AM from S. moorei cells. Cells treated with PBS or heat
ta are expressed as means ± standard deviations.
Figure 3 Effect of green tea extract and EGCG surface pre-treatments on biofilm formation by S. moorei in a microplate assay model.
A relative value of 100% was assigned to control in which wells were pre-treated with PBS. Data are expressed as means ± standard deviations.
*, significant inhibition (P < 0.01) compared to control.
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either green tea extract or EGCG, the adherence of
S. moorei to oral epithelial cells was dose-dependently
inhibited (Figure 5). At the highest concentration tested
(200 μg/ml) the inhibition caused by EGCG was more
significant.
Given that a previous study [26] showed that the β-
galactosidase activity of S. moorei plays a key role in
VSC production by the bacterium, we tested whether
green tea polyphenols can inhibit the activity and gene ex-
pression of β-galactosidase. Table 2 reports that both green
tea extract and EGCG, at a concentration ≥ 125 μg/ml,
caused a significant inhibition of S. moorei cell-associated
β-galactosidase activity. More specifically, at 250 μg/ml
green tea extract and EGCG caused an inhibition of 66.7%
and 61.5%, respectively. The effect of green tea polyphenols
on β-galactosidase gene expression, as determined by quan-
titative PCR, is reported in Figure 6. On the one hand,
when used at their MIC, both green tea extract and EGCGincreased β-galactosidase gene expression. On the other
hand, at ½ of their MIC, while green tea extract had no ef-
fect, EGCG significantly decreased (33%) the gene expres-
sion of β-galactosidase.
Discussion
Halitosis or oral malodor is in most cases caused by the
production of VSCs, particularly methyl mercaptan and
hydrogen sulfide, by specific bacterial species colonizing
the gingival sulcus as well as the dorso-posterior region
of the tongue [15]. It is estimated that up to half of the
adult population is affected by halitosis, although epide-
miologic studies using objective criteria showed that the
prevalence may be lower [32-34]. Given its high preva-
lence in halitosis subjects, the Gram-positive strictly an-
aerobic bacterium S. moorei is considered as a key
causative agent of halitosis [22-25]. In addition, it has also
been associated with various types of dental infections
such as endodontic infections [35,36], and refractory
Figure 4 Effect of green tea extract and EGCG on desorption of a pre-formed S. moorei biofilm in a microplate assay model. A relative
value of 100% was assigned to control in which biofilms were pre-treated with PBS. Data are expressed as means ± standard deviations.
*, significant inhibition (P < 0.01) compared to control.
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tosis in the general population, the strong association of
S. moorei with this condition, and the growing interest of
companies for natural plant molecules as efficacious and
safe substances for oral care products (mints, gum,
mouthwash, etc.), this study examined the effects of green
tea extract and EGCG on growth and various halitosis-
related properties of S. moorei.
Green tea, the non-fermented form of tea, is consid-
ered as a functional food since it has positive health ef-
fects that extend beyond its nutritional value [8]. The
most abundant polyphenol of green tea and the one that
has been extensively studied is EGCG [1]. More specific-
ally, Wu and Wei [4] reported that a cup of green tea
(2.5 g of green tea leaves/200 ml of water) may contain
up to 90 mg of EGCG. Recent studies have suggested
that green tea polyphenols may be regarded as molecules
of interest for the management of oral diseases, includ-
ing dental caries and periodontitis [4-13]. In this study,
we uncovered new properties associated with green tea
polyphenols, including EGCG, that support their poten-
tial for controlling halitosis.
We first showed that a green tea extract as well as its
main constituent EGCG can efficiently inhibit the
growth of S. moorei, with MICs of 500 and 250 μg/ml,
respectively. In regard to MBCs, a value of 4000 μg/ml
was obtained for green tea extract while that of EGCG
was >4000 μg/ml. This suggests that green tea extract may
contain additional bioactive components, in addition to
EGCG, that can exert bactericidal action. These values arein agreement with those previously reported for other oral
pathogens, including P. gingivalis [12]. Since the cell
membrane is a target of many plant polyphenols, we in-
vestigated the effect of green tea polyphenols on S. moorei
cell integrity by transmission electron microscopy and a
membrane permeabilization assay. While the green tea ex-
tract did not markedly affect the bacterial ultrastructure,
EGCG was found to induce major damages. Both green
tea extract and EGCG appear to permeabilize the cell
membrane resulting in calcein-AM leakage. Previous stud-
ies also reported that tea theaflavins and catechins can ir-
reversibly damage the bacterial cytoplasmic membrane
[38-40]. In regard to EGCG, it generates hydrogen perox-
ide in the lipid bilayer of the bacterial cytoplasmic mem-
brane, resulting in leakage of intracellular materials [40].
Additional mechanisms by which green tea polyphenols
inhibit the growth of S. moorei may be involved. For in-
stance, Navarro-Martinez et al. [41] provided evidence
that the antibacterial action of catechins against Stenotro-
phomonas maltophila, a Gram-negative opportunistic
pathogen, is due to its ability to inhibit cytoplasmic dihy-
drofolate reductase. Dihydrofolate reductase reduces dihy-
drofolic acid to tetrahydrofolic acid, which is required by
bacteria to synthetize purine, thymidylate, and nucleic acid
precursors, which are very important for cell proliferation
and growth.
Biofilm formation by S. moorei is likely a key step in
halitosis. Although green tea polyphenols did not show
any specific anti-biofilm effect on S. moorei, we showed
that it can affect the biofilm via two mechanisms. First,
Figure 5 Effect of green tea extract and EGCG on adherence of S. moorei to oral epithelial cells. Data are expressed as means ± standard
deviations. *, significant inhibition (P < 0.01) compared to control.
Table 2 Effect of green tea extract and EGCG on
β-galactosidase activity of S. moorei
Compound % inhibition of
β-galactosidase activity
None (control) 0
Green tea extract 500 μg/ml 75.4 ± 9.3*
250 μg/ml 66.7 ± 11.2*
125 μg/ml 43.6 ± 13.7*
62.5 μg/ml 17.3 ± 10.1
EGCG 500 μg/ml 72.1 ± 9.8*
250 μg/ml 61.5 ± 15.7*
125 μg/ml 53 ± 9.5*
62.5 μg/ml 26.4 ± 12.3
*Significantly different at P < 0.01 compared to control.
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surfaces was significantly affected. Second, both green
tea extract and EGCG can cause the eradication of pre-
formed S. moorei biofilms. The mechanism involved in
biofilm desorption may be related to the ability of green
tea polyphenols to alter the cell integrity of S. moorei.
Both the green tea extract and EGCG were also found to
reduce the adherence of S. moorei to oral epithelial cells.
This is in agreement with previous data reported by our la-
boratory showing that tea extracts (green, white, black, and
oolong) can prevent the adherence of P. gingivalis to epi-
thelial cells [13]. This inhibition may be related to the bind-
ing of green tea polyphenols to the bacterial cell surface
thus altering the hydrophobicity or hiding adhesins.
In a previous study, we showed that S. moorei produces
high levels of VSCs when cultivated in the presence of
cysteine and that its cell-associated β-galactosidase is es-
sential for VSC production from mucin [26]. This enzyme
can deglycosylate salivary glycoproteins, which can be fur-
ther degraded into peptides and amino acids by host and
Figure 6 Effect of green tea extract and EGCG on mRNA expression of β-galactosidase gene in S. moorei. Bacteria were incubated (8 h) in
the presence of compounds at MIC (500 and 250 μg/ml for green tea extract and EGCG, respectively), and ½ MIC (250 and 125 μg/ml for green tea
extract and EGCG, respectively). Data are expressed as means ± standard deviations. The expression was normalized to 16S rRNA. *, significantly
different (P < 0.01) compared to untreated control.
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VSCs. Interestingly, β-galactosidase activity in saliva has
been associated with halitosis [42,43]. In this study, we
showed that green tea extract and EGCG inhibit β-
galactosidase activity of S. moorei, a property that may
contribute to reduce oral malodor. The ability of green
tea polyphenols to attenuate the β-galactosidase gene
expression in S. moorei was also investigated. It was
found that when used at MIC, both the green tea extract
and EGCG up-regulate gene expression while at ½ MIC,
EGCG significantly decreased the β-galactosidase gene
expression whereas the green tea extract has no effect.
Interestingly, Xu et al. [44] recently reported that sub-
minimal inhibitory concentrations of EGCG suppress
the gene expression of L-methionine-α-deamino-γ-mer-
captomethane lyase, a P. gingivalis enzyme involved in
methyl mercaptan production.Data presented in this study, strongly suggest that
green tea polyphenols deserve to be considered as
promising compounds for the management of hali-
tosis. Additional polyphenols were also reported to
possess beneficial properties in regard to halitosis. A
licorice extract as well as isoflavanones (licoricidin
and licorisoflavan A) isolated from this fraction were
found to inhibit the growth of S. moorei, P. gingivalis,
and Prevotella intermedia as well as to dose-
dependently reduce VSC production by these three
bacterial species [45]. Moreover, Forrer et al. [46] re-
cently reported that tea tree oil and alpha-bisabolol,
plant essential oils contained in tongue gels and tooth-
pastes, exert a bactericidal effect on S. moorei and there-
fore can be effective against halitosis. Further studies
should evaluate whether combining the above natural
compounds may result in synergistic effects.
Morin et al. BMC Complementary and Alternative Medicine  (2015) 15:48 Page 10 of 11Conclusions
The initial therapy for halitosis consists in a mechanical
scraping of the dorsum of the tongue to remove the biofilm
also called tongue coating. An antimicrobial approach may
also contribute to decrease tongue coating and reduce oral
malodor. Our study brought evidence to support that green
tea extract or EGCG possess a number of properties that
may contribute to reduce S. moorei-related halitosis. There-
fore, these natural compounds may be of interest to be used
to supplement oral healthcare products.
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